Dosing information for paediatric patients: Are they really "therapeutic orphans"?

Medical Journal of Australia

Volumn 179, Issue 4, 2003, Pages 195-198

  Tan, Elaine ^a,b   Cranswick, Noel E ^b   Rayner, Craig R ^a   Chapman, Colin B ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXICILLIN; AZATHIOPRINE; CARDIOVASCULAR AGENT; CEFALEXIN; CLOMIFENE; CLONAZEPAM; FUROSEMIDE; GENERIC DRUG; IMMUNOSUPPRESSIVE AGENT; PENICILLIN V; PROPRANOLOL; TAMOXIFEN;

ADOLESCENT; AGE; ARTICLE; AUSTRALIA; BIOEQUIVALENCE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD DISEASE; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG INDICATION; DRUG INFORMATION; HUMAN; INFANT; INFECTION; METABOLIC DISORDER; NEOPLASM; NEWBORN; PEDIATRICS; PRESCRIPTION; VALIDATION PROCESS;

EID: 0041926456     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05498.x     Document Type: Article

References (19)

1. Report of the Working Party on the Registration of Drugs for Use in Children. Canberra: Australian Drug Evaluation Committe, 1997.
2. Wilson JT. Pragmatic assessment of medicines available for young children and pregnant or breast-feeding women. In: Morsellin PL, Garattini S, Sereni F, editors. Basic and Therapeutic Aspects of Perinatal Pharmacology. New York: Raven Press, 1975: 411-421.
3. Gilman JT, Gal P. Pharmacokinetic and pharmacodynamic data collection in children and neonates: A quiet frontier. Clin Pharmacokinet 1992; 23: 1-9.
4. 't Jong GW, Eland IA, Stricker BH, et al. Information for paediatric use of medicines in a product information compendium. Paediatr Perinat Drug Ther 2001; 4: 148-151.
5. Shirkey H. Therapeutic orphans [editorial]. J Pediatr 1968; 72: 119-120.
6. Barker C, Nunn AJ, Turner S. Paediatrics. In: Walker R, Edwards C, editors. Clinical Pharmacy and Therapeutics. 3rd ed. Edinburgh: Churchill Livingstone, 2003: 111-126.
7. Christensen ML, Helms RA, Chesney RW. Is pediatric labeling really necessary? Pediatrics 1999; 104 (3 Pt 2): 593-597.
8. Nunn AJ. Making medicines that children can take. Arch Dis Child 2003; 88: 369-371.
9. MIMS Australia. 1999 MIMS Annual. 23rd ed. Sydney: MediMedia Australia Pty Ltd, 1999.
10. E-MIMS [Computer Program]. Version 4.00.0500. Sydney: Vivendi Universal Health, August 2001.
11. Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group. Medicines for Children. London: Royal College of Paediatrics and Child Health, 1999.
12. MINITAB [Computer Program]. Version 12.23. State College, Pa: Minitab Inc., 1999.
13. SYSTAT [Computer Program]. Version 10. Chicago, Ill: SPSS Inc., 2000.
14. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners, February 2003. Canberra: Commonwealth Department of Health and Ageing, 2003.
15. Conroy S, McIntyre J, Choonara I, et al. Drug trials in children: Problems and the way forward. Br J Clin Pharmacol 2000; 49: 93-97.
16. Nordenberg T. Pediatric drug studies. Protecting pint-sized patients. FDA Consum 1999; 33: 23-28.
17. European Medicines Evaluation Agency. Note for guidance on clinical investigation of medicinal products in the paediatric population. London: EMEA, 1999. Available at: www.emea.eu.int/pdfs/human/ich/271199EN.pdf (accessed Jul 2003).
18. Therapeutic Goods Administration. Medicines for paediatric use. TGA News March 2002; Issue 37.
19. Collier J. Paediatric prescribing: Using unlicensed drugs and medicines outside their licensed indications. Br J Clin Pharmacol 1999; 48: 5-8.